Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test

NCT06864338 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2700

Last updated 2025-08-12

No results posted yet for this study

Summary

The Mainz Biomed Colorectal Cancer Screening Test is being studied for its performance in the identification of the presence of colorectal cancer (CRC) or advanced adenoma (AA) in the colon in patients at average risk for colorectal cancer.

Conditions

  • Colorectal Cancer Screening
  • Colorectal Cancer Metastatic
  • Colon Adenocarcinoma

Sponsors & Collaborators

  • Mainz Biomed

    lead INDUSTRY

Principal Investigators

  • Robert Bresalier, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-18
Primary Completion
2025-11-30
Completion
2025-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06864338 on ClinicalTrials.gov